# Innovative technologies to transform antibiotic discovery.  Administrative Core

> **NIH NIH U19** · BROAD INSTITUTE, INC. · 2020 · $3,052,404

## Abstract

ABSTRACT
 The goal of our proposal is to establish an interdisciplinary center - Center for Innovation to Transform
Antibiotic Discovery (CITADel) - that will deliver 1) pre-clinical antimicrobial candidates that target the unmet
therapeutic needs of the most clinically important drug-resistant Gram-negative pathogens today –
Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae (CREs); and 2) novel drug-
discovery platforms upon which future therapeutics - beyond those that will be delivered from this award - can
be developed. CITADel's unique approach to drug discovery and development is grounded in a close alliance -
throughout the drug discovery and development process - between academic investigators, industrial partners,
clinicians, and regulatory experts – from the very outset of all scientific efforts.
 We will establish an Administrative Core that will manage and oversee the four highly integrated and
 synergistic research projects of CITADel. Responsibilities include providing support to all research projects
 on administrative deliverables, monitoring the timelines and deliverables of all research projects, in addition to
 those of the Center, organizing programmatic meetings and NIAID site visits, providing regulatory guidance to
 all research projects to ensure successful translation of the developed therapeutics into the clinic, creating
 commercialization strategies for therapeutic agents, coordinating communication within the program and with
 NIAID, and identifying and resolving program inefficiencies.
 The Administrative Core will also establish and coordinate the activities of 1) two Intramural Steering
Committees – the Scientific Steering Committee and the Clinical Development Steering Committee – which
collectively provide scientific, clinical and regulatory guidance to the research projects; and 2) an Extramural
Scientific Oversight Committee – composed of a Scientific Advisory Committee and NIAID – which will provide
and external guidance and support to CITADel and its projects.
 The Administrative Core will be established under the leadership of Deborah Hung (Director of CITADel
and the Administrative Core), and the co-leadership of Laura Kiessling (Associate Director of CITADel and the
Administrative Core) and Helen Boucher (Regulatory Director of the Administrative Core).
!

## Key facts

- **NIH application ID:** 9990680
- **Project number:** 5U19AI142780-02
- **Recipient organization:** BROAD INSTITUTE, INC.
- **Principal Investigator:** DEBORAH T HUNG
- **Activity code:** U19 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $3,052,404
- **Award type:** 5
- **Project period:** 2019-08-07 → 2024-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9990680

## Citation

> US National Institutes of Health, RePORTER application 9990680, Innovative technologies to transform antibiotic discovery.  Administrative Core (5U19AI142780-02). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9990680. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*